• Home
  • About Us
    About Us
    Since the establishment of JSBio, we have been loyal in our pursuit to offer “Quality First” as our highest priority of business.
    Company Overview
    Mission/ Vision/ Values
    History/ Adwards
    Facilities and Manufacturing Capacity
    Quality Systems
    Logistics and Warehouse
    Supply Chain Sustainability
    Join Us
    Work and Living Environment
    Growth & Development Potentials
    Hiring (Open Positions)
  • Products
  • Services
  • Resources
    Resources
    Product Archives
    Certificate of Quality
    FAQ
    White Paper
    Product & Service References
    Video References
  • News
    News
    Public News
    Events
  • Contact Us
CN
EN
CN
菜单
  • Home
  • About Us
    • Company Overview
    • Mission/ Vision/ Values
    • History/ Adwards
    • Facilities and Manufacturing Capacity
    • Quality Systems
    • Logistics and Warehouse
    • Supply Chain Sustainability
    • Join Us
    • Work and Living Environment
    • Growth & Development Potentials
    • Hiring (Open Positions)
  • Products
    • Basal Media
    • Customized Media
    • Supplements and Buffers
  • Services
  • Resources
  • News
    • Public News
    • Events
  • Contact Us
  • CN
news
  1. Home
  2. Press Release
  3. news
Select All
  • Select All
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
Search Result: 11 articles
  • 2022.10.31
    JS Biosciences Co., Ltd receives industry certifications for the newly-constructed Nantong manufacturing site
    Read More
  • 2021.12.28
    Thousand Oaks Biologics receives $236 Million for Expansion of Cell Culture Media Development and CDMO Servicing
    Read More
  • 2021.09.12
    XieYi Lanzhou: The balance between the quality and cost of biological drugs
    Read More
  • 2021.09.04
    Jianshun Biosciences is named to the “Little Giant” list of new businesses on the rise in China
    Read More
  • 2021.04.28
    JSBio assists North China Pharmaceutical in completing Please III clinical trials for a recombinant immunotherapy injection that treats the human rabies virus (rhRIG)
    Read More
  • 2021.04.25
    Help fighting the epidemic – Jianshun Biosciences was awarded as the ‘Outstanding Contribution Supplier’ from CanSino Biologics Inc.
    Read More
  • 2021.04.08
    We proudly announce opening of JSBio's second cell culture medium production facility
    Read More
  • 2021.02.06
    Thousand Oaks Biologics and Shanghai Henlius Biotech Inked Strategic Collaboration
    Read More
  • 2020.09.03
    Jianshun Biosciences and Boan Bio partner to speed up and simplify biologics manufacturing worldwide
    Read More
    上一页12一页»
  • 0931-7706502

  • About Us
    Company Overview
    Mission/ Vision/ Values
    History/ Adwards
    Facilities and Manufacturing Capacity
    Quality Systems
    Logistics and Warehouse
    Supply Chain Sustainability
    Join Us
    Work and Living Environment
    Growth & Development Potentials
    Hiring (Open Positions)
  • Products
    Basal Media
    Customized Media
    Supplements and Buffers
  • Services
    Custom Media Manufacturing (Powder & Liquid)
    Media Formulation Development
    Transient Transfection
    Cell Line Development
    CHO Cell Culture Process Development
    Cell Culture Process Development for Human & Veterinary Vaccine
    Non-GMP Production of Recombinant Protein
    GMP Manufacturing of Biologics – CDMO
  • Resources
    Product Archives
    Certificate of Quality
    FAQ
    White Paper
    Product & Service References
    Video References
  • News
    Public News
    Events
More About JSBio’s Corporate company
Thousand Oaks Biologics
Copyright © 2022 JSBiosciences. All Rights Reserved. 陇ICP备15002644号-1 京公网安备62010502000246号
User Terms Privacy Policy Site Map